Open1.120 | Close1.140 |
Vol / Avg.218.036K / 190.159K | Mkt Cap22.801M |
Day Range1.060 - 1.190 | 52 Wk Range1.030 - 9.120 |
Mainz Biomed Stock (NASDAQ: MYNZ) stock price, news, charts, stock research, profile.
Open1.120 | Close1.140 |
Vol / Avg.218.036K / 190.159K | Mkt Cap22.801M |
Day Range1.060 - 1.190 | 52 Wk Range1.030 - 9.120 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.470 | -0.390 | 0.0800 | ||||
REV | 330.000K | 181.669K | -148.331K |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.420 | -0.560 | -0.1400 | ||||
REV | 248.945K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-11-21 | Cantor Fitzgerald | Ross Osborn | Downgrades | OverweightNeutral | - | - | - |
2023-11-20 | HC Wainwright & Co. | Yi Chen | Maintains | BuyBuy | Lowers | 9.00 | 5.00 |
2023-09-26 | Cantor Fitzgerald | Ross Osborn | Reiterates | OverweightOverweight | Maintains | - | 9.00 |
2023-09-22 | HC Wainwright & Co. | Yi Chen | Maintains | BuyBuy | Raises | 7.00 | 9.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
MYNZ | Mainz Biomed | 3.7% | 22.8M |
CLRB | Cellectar Biosciences | 10.71% | 24.7M |
LUMO | Lumos Pharma | -7.28% | 22.2M |
EVAX | Evaxion Biotech | 11.78% | 24.3M |
SNSE | Sensei Biotherapeutics | -4.63% | 17M |
You can purchase shares of Mainz Biomed (NASDAQ: MYNZ) through any online brokerage.
Other companies in Mainz Biomed’s space includes: Cellectar Biosciences (NASDAQ:CLRB), Lumos Pharma (NASDAQ:LUMO), Evaxion Biotech (NASDAQ:EVAX), Sensei Biotherapeutics (NASDAQ:SNSE) and NuCana (NASDAQ:NCNA).
The latest price target for Mainz Biomed (NASDAQ: MYNZ) was reported by Cantor Fitzgerald on Tuesday, November 21, 2023. The analyst firm set a price target for 0.00 expecting MYNZ to fall to within 12 months (a possible -100.00% downside). 13 analyst firms have reported ratings in the last year.
The stock price for Mainz Biomed (NASDAQ: MYNZ) is $1.12 last updated November 30, 2023 at 2:22 PM UTC.
There is no dividend information for Mainz Biomed.
Mainz Biomed’s Q3 earnings are confirmed for Thursday, November 16, 2023.
There is no upcoming split for Mainz Biomed.
Mainz Biomed is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.